Sort
25,944 grants matching “neurodegeneration”
Experimental Creutzfeldt Jacob Disease
$539,613Laura Manuelidis · Yale University · R01 · FY2010 · NS
Structural Biology of Genome Maintenance and DNA repair
$539,561Robert Williams · National Institute Of Environmental Health Sciences · ZIA · FY2010 · ES
The Hippo signaling pathway as a target of intervention for Alzheimerâs disease
$539,512Qitao Ran · University Of Texas Hlth Science Center · R01 · FY2024 · AG
Enhancing Alzheimer's-related research in rural South Africa with portable MRI
$539,352Adam M Brickman · Columbia University Health Sciences · UG3 · FY2025 · AG
Topical drug delivery formulations for neuroprotection in glaucoma
$539,249Laura Ensign · Johns Hopkins University · R01 · FY2024 · EY
CORE A: Administrative Core
$539,248Jessica Kirkland Caldwell · Cleveland Clinic Foundation · P20 · FY2023 · GM
Longitudinal predictive modeling for tau in Alzheimer's disease
$539,013Joyita Dutta · Massachusetts General Hospital · R01 · FY2024 · AG
Longitudinal predictive modeling for tau in Alzheimer's disease
$539,013Joyita Dutta · Massachusetts General Hospital · R01 · FY2023 · AG
Regulation of Mesenchymal Stem Cell Secretome for Treatment of Microglia Damage in Traumatic Brain Injury
$539,000Rajashekhar Gangaraju · University Of Tennessee Health Sci Ctr · R56 · FY2022 · NS
A Unified Atlas of Dynamic tRNA Function
$538,908Todd Michael Lowe · University Of California Santa Cruz · R01 · FY2020 · HG
Project 4: Novel reagent development to enable molecular characterization
$538,902David Baker · University Of Washington · U19 · FY2020 · AG
Genes, Exercise, Neurocognitive and Neurodegeneration: Community-Based Approach
$538,867Thomas O Obisesan · Howard University · R01 · FY2015 · AG
A Unified Atlas of Dynamic tRNA Function
$538,836Todd Michael Lowe · University Of California Santa Cruz · R01 · FY2022 · HG
Mechanisms of motor neuron toxicity in Kennedy disease
$538,742Andrew P Lieberman · University Of Michigan At Ann Arbor · R01 · FY2019 · NS
Developing Neuroprotective Strategies for Tau and TDP-43 Proteinopathy in FTLD
$538,722Brian C. Kraemer · Seattle Inst For Biomedical/Clinical Res · R01 · FY2021 · NS
Characterization of the Mitochondrial Proteome
$538,657Vamsi Krishna Mootha · Broad Institute, Inc. · R01 · FY2013 · GM
Project 3: Inhibition of L1 to Alleviate Alzheimer's Disease Pathogenosis in Mouse Models
$538,611Vera Gorbunova · Brown University · P01 · FY2025 · AG
Linking metabolism, neural function, and aging
$538,582Kaveh Ashrafi · University Of California, San Francisco · R01 · FY2019 · AG
SCA7 neurodegeneration: molecular epigenetic basis and therapy development
$538,508Albert R La Spada · University Of California, San Diego · R01 · FY2016 · EY
Glucose metabolism, synaptic plasticity, and oxidative stress in Alzheimer's Disease
$538,455Rajiv R Ratan · Winifred Masterson Burke Med Res Inst · P01 · FY2016 · AG
Roles of Cdk5 in neurodevelopment and neurodegeneration
$538,425Edward Giniger · National Institute Of Neurological Disorders And Stroke · ZIA · FY2010 · NS
Brain Oxygen Metabolism and Hemodynamic Impairment in Multiple Sclerosis
$538,305Yulin Ge · New York University School Of Medicine · R01 · FY2016 · NS
Brain Oxygen Metabolism and Hemodynamic Impairment in Multiple Sclerosis
$538,305Yulin Ge · New York University School Of Medicine · R01 · FY2015 · NS
Temporal control of mitochondrial mutagenesis
$538,174Marc Vermulst · University Of Southern California · R01 · FY2025 · AG
Training in Basic Aging Research and Age-Related Disease
$538,160Judith Campisi · Buck Institute For Research On Aging · T32 · FY2008 · AG